The effect of age on immunologic response to recombinant hepatitis B vaccine: A meta-analysis

David N. Fisman, Deepak Agrawal, Karin Leder

Research output: Contribution to journalArticle

140 Citations (Scopus)

Abstract

Hepatitis B vaccine is a key tool for the prevention of hepatitis B infection. Age-associated changes in immune function may contribute to decreased vaccine efficacy in older individuals, although research related to this topic has yielded contradictory findings. We performed a meta-analysis of 24 published trials and studies that evaluated the association of age with response to hepatitis B vaccine, using a random-effects model. Pooling of study results suggested a significantly increased risk of nonresponse to hepatitis B vaccine among older individuals (relative risk [RR], 1.76; 95% confidence interval [CI], 1.48-2.10). An elevated risk of nonresponse persisted even after exclusion of poor-quality studies (RR, 1.63; 95% CI, 1.23-2.15) and adjustment for publication bias (RR, 1.52; 95% CI, 1.26-1.83), and it was present even when " older" individuals were defined as being as young as 30 years. These findings have important implications for individuals at risk for hepatitis B infection, including health care workers and travelers.

Original languageEnglish (US)
Pages (from-to)1368-1375
Number of pages8
JournalClinical Infectious Diseases
Volume35
Issue number11
DOIs
StatePublished - Dec 1 2002
Externally publishedYes

Fingerprint

Hepatitis B Vaccines
Synthetic Vaccines
Meta-Analysis
Confidence Intervals
Hepatitis B
Publication Bias
Infection
Vaccines
Delivery of Health Care
Research

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

The effect of age on immunologic response to recombinant hepatitis B vaccine : A meta-analysis. / Fisman, David N.; Agrawal, Deepak; Leder, Karin.

In: Clinical Infectious Diseases, Vol. 35, No. 11, 01.12.2002, p. 1368-1375.

Research output: Contribution to journalArticle

Fisman, David N. ; Agrawal, Deepak ; Leder, Karin. / The effect of age on immunologic response to recombinant hepatitis B vaccine : A meta-analysis. In: Clinical Infectious Diseases. 2002 ; Vol. 35, No. 11. pp. 1368-1375.
@article{402a27944b074a05a8784c2c4f3da210,
title = "The effect of age on immunologic response to recombinant hepatitis B vaccine: A meta-analysis",
abstract = "Hepatitis B vaccine is a key tool for the prevention of hepatitis B infection. Age-associated changes in immune function may contribute to decreased vaccine efficacy in older individuals, although research related to this topic has yielded contradictory findings. We performed a meta-analysis of 24 published trials and studies that evaluated the association of age with response to hepatitis B vaccine, using a random-effects model. Pooling of study results suggested a significantly increased risk of nonresponse to hepatitis B vaccine among older individuals (relative risk [RR], 1.76; 95{\%} confidence interval [CI], 1.48-2.10). An elevated risk of nonresponse persisted even after exclusion of poor-quality studies (RR, 1.63; 95{\%} CI, 1.23-2.15) and adjustment for publication bias (RR, 1.52; 95{\%} CI, 1.26-1.83), and it was present even when {"} older{"} individuals were defined as being as young as 30 years. These findings have important implications for individuals at risk for hepatitis B infection, including health care workers and travelers.",
author = "Fisman, {David N.} and Deepak Agrawal and Karin Leder",
year = "2002",
month = "12",
day = "1",
doi = "10.1086/344271",
language = "English (US)",
volume = "35",
pages = "1368--1375",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "11",

}

TY - JOUR

T1 - The effect of age on immunologic response to recombinant hepatitis B vaccine

T2 - A meta-analysis

AU - Fisman, David N.

AU - Agrawal, Deepak

AU - Leder, Karin

PY - 2002/12/1

Y1 - 2002/12/1

N2 - Hepatitis B vaccine is a key tool for the prevention of hepatitis B infection. Age-associated changes in immune function may contribute to decreased vaccine efficacy in older individuals, although research related to this topic has yielded contradictory findings. We performed a meta-analysis of 24 published trials and studies that evaluated the association of age with response to hepatitis B vaccine, using a random-effects model. Pooling of study results suggested a significantly increased risk of nonresponse to hepatitis B vaccine among older individuals (relative risk [RR], 1.76; 95% confidence interval [CI], 1.48-2.10). An elevated risk of nonresponse persisted even after exclusion of poor-quality studies (RR, 1.63; 95% CI, 1.23-2.15) and adjustment for publication bias (RR, 1.52; 95% CI, 1.26-1.83), and it was present even when " older" individuals were defined as being as young as 30 years. These findings have important implications for individuals at risk for hepatitis B infection, including health care workers and travelers.

AB - Hepatitis B vaccine is a key tool for the prevention of hepatitis B infection. Age-associated changes in immune function may contribute to decreased vaccine efficacy in older individuals, although research related to this topic has yielded contradictory findings. We performed a meta-analysis of 24 published trials and studies that evaluated the association of age with response to hepatitis B vaccine, using a random-effects model. Pooling of study results suggested a significantly increased risk of nonresponse to hepatitis B vaccine among older individuals (relative risk [RR], 1.76; 95% confidence interval [CI], 1.48-2.10). An elevated risk of nonresponse persisted even after exclusion of poor-quality studies (RR, 1.63; 95% CI, 1.23-2.15) and adjustment for publication bias (RR, 1.52; 95% CI, 1.26-1.83), and it was present even when " older" individuals were defined as being as young as 30 years. These findings have important implications for individuals at risk for hepatitis B infection, including health care workers and travelers.

UR - http://www.scopus.com/inward/record.url?scp=0036901212&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036901212&partnerID=8YFLogxK

U2 - 10.1086/344271

DO - 10.1086/344271

M3 - Article

C2 - 12439800

AN - SCOPUS:0036901212

VL - 35

SP - 1368

EP - 1375

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 11

ER -